![Jeffrey Hackman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Hackman
Algemeen Directeur bij
FENNEC PHARMACEUTICALS INC.
Vermogen: 623 419 $ op 31-07-2026
Profiel
Jeffrey S Hackman is currently the Chairman & Chief Executive Officer at Comera Life Sciences, Inc. and the Chief Executive Officer & Director at Fennec Pharmaceuticals, Inc. Previously, he held positions as the Chairman, President & Chief Executive Officer at Comera Life Sciences Holdings, Inc., Chief Operating Officer & Director at Leadiant Biosciences, Inc., Chief Operating Officer & Director at Sigma-tau Healthscience USA, Inc., SVP-US Internal Medicine & Oncology franchise at Shire Plc, Vice President & Head-North America Region at Baxalta US, Inc., and Chief Executive & Operating Officer, Executive VP at Novelion Therapeutics, Inc. He obtained his undergraduate degree from Lycoming College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-08-2026 | 65.143 ( 0,19% ) | 623 419 $ | 31-07-2026 |
Actieve functies van Jeffrey Hackman
| Bedrijven | Functie | Begin |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Algemeen Directeur | 16-08-2024 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Algemeen Directeur | 08-09-2021 |
Eerdere bekende functies van Jeffrey Hackman
| Bedrijven | Functie | Einde |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Algemeen Directeur | 31-01-2024 |
| NOVELION THERAPEUTICS INC. | Algemeen Directeur | 20-11-2018 |
Sigma-tau Healthscience USA, Inc.
 Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation | Operationeel Directeur | - |
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Engages in the research, development, and manufacture of biopharmaceutical products | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
Opleiding van Jeffrey Hackman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
41
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Lycoming College
 Lycoming College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Engages in the research, development, and manufacture of biopharmaceutical products | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Sigma-tau Healthscience USA, Inc.
Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
